Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Pharma
RemeGen, Roche, Hengrui and more—Fierce Pharma Asia
Pfizer and RemeGen's HER2 ADC posted a phase 3 win. Roche plans to build a new Chinese plant. Hengrui gears up for a Hong Kong IPO. And more.
Angus Liu
May 16, 2025 10:20am
Merck KGaA tweaks 2025 forecast as geopolitical concerns mount
May 15, 2025 1:20pm
Merck KGaA jumps back into M&A game with $3.9B SpringWorks buyout
Apr 28, 2025 11:09am
Merck KGaA confirms talks with SpringWorks about $3.5B buyout
Apr 25, 2025 8:12am
Pharmas' Xi meeting; Tariffs; BioNTech—Fierce Pharma Asia
Apr 4, 2025 8:30am
Pharma CEOs meet with Xi Jinping amid US-China trade tensions
Mar 28, 2025 10:49am
